Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Queensland Health
Baxter
Fuji
McKesson
Colorcon
Healthtrust
Covington
Cantor Fitzgerald
Johnson and Johnson

Generated: February 23, 2018

DrugPatentWatch Database Preview

ACETYLCYSTEINE Drug Profile

« Back to Dashboard

When do Acetylcysteine patents expire, and when can generic versions of Acetylcysteine launch?

Acetylcysteine is a drug marketed by Akorn Inc, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Mylan Institutional, Sagent Pharms, Alvogen Inc, Hospira, Luitpold, and Roxane. and is included in seventeen NDAs.

The generic ingredient in ACETYLCYSTEINE is acetylcysteine. There are three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.

US Patents and Regulatory Information for ACETYLCYSTEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 203173-001 Mar 24, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alvogen Inc ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 203853-001 Jun 21, 2012 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 203624-001 Jun 19, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 072489-001 Jul 28, 1995 AN RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 071364-001 May 1, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 072324-001 Apr 30, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 072323-001 Apr 30, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 207358-001 Feb 29, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 200644-001 Nov 7, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alvogen Inc ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 204674-001 Feb 11, 2014 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Medtronic
Boehringer Ingelheim
Deloitte
Teva
UBS
Chubb
Farmers Insurance
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot